SuperworthLiminatus Pharma shares outstanding LIMN
Diluted shares outstanding, averaged over each quarter, from 2024.
- Latest quarter, to Jun 30, 2026
- 968K
- On a year earlier
- +107.7%
- more shares
Liminatus Pharma had 968K diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 107.7% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 541.3K | +55% |
| FY2024 | 350K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 968K | +108% | |
| Q1 FY26 | 720K | +106% | |
| Q4 FY25 | 541.3K | +55% | |
| Q3 FY25 | 540.2K | +54% | |
| Q2 FY25 | 466K | +33% | |
| Q1 FY25 | 350K | +17499900% | |
| Q4 FY24 | 350K | n/a | |
| Q3 FY24 | 350K | n/a | |
| Q2 FY24 | 350K | n/a | |
| Q1 FY24 | 2 | n/a |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Liminatus Pharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.